FindMyKOL
Clinical trialNCT03388749CompletedPhase 1/PHASE2Interventional

Study of Liposomal Annamycin for the Treatment of Subjects With Acute Myeloid Leukemia (AML)

SponsorMoleculin Biotech, Inc.Enrollment20Leukemia, Myeloid, Acute
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This is a multi-center, open-label, dose escalation study that will determine the maximum tolerated dose (MTD) and recommended Phase 2 dose (RP2D) of liposomal annamycin as a single agent for the treatment of subjects with AML that is refractory to or relapsed after induction therapy
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a FindMyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

5 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

Poland
  • Medical University of Lodz

    Lodz, Poland

  • Szpital Kliniczny Przemienienia Pańskiego Uniwersytetu Medycznego Im. Karola Marcinkowskiego

    Poznan, Poland

  • Samodzielny Publiczny Szpital Kliniczny Nr 1 Im. Prof. Tadeusza Sokołowskiego W Szczecinie, Klinika Hematologii Z Oddziałem Transplantacji Szpiku

    Szczecin, Poland

  • Instytut Hematologii I Transfuzjologii, Klinika Hematologii

    Warsaw, Poland

  • Samodzielny Szpital Kliniczny Nr 1

    Wroclaw, Poland

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Liposomal Annamycin
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
17 Dec 2018
Primary completion
8 Feb 2022
Completion
14 Feb 2022
Last update posted
20 Jan 2023
Registered enrollment
20
Registry id
NCT03388749
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; FindMyKOL does not interpret them.